Abstract
Background:
Coronavirus disease 2019 (COVID-19) is posing a huge threat to human health worldwide. We aim to investigate the immune status of CD8+ T and NK cells in COVID-19 patients.
Methods:
The count and immune status of lymphocytes were detected by flow cytometry in 32 COVID-19 patients and 18 healthy individuals.
Results:
As the disease progression in COVID-19 patients, CD8+ T and NK cells were significantly decreased in absolute number but highly activated. After patients' condition improved, the count and immune status of CD8+ T and NK cells restored to some extent. GrA+CD8+ T and perforin+ NK cells had good sensitivity and specificity for assisting diagnosis of COVID-19.
Conclusions:
As the disease progression, the declined lymphocytes in COVID-19 patients might lead to compensatory activation of CD8+ T and NK cells. GrA+CD8+ T and perforin+ NK cells might be used as meaningful indicators for assisting diagnosis of COVID-19.
Keywords:
CD8(+) T cells; COVID-19; Granzyme; NK cells; Perforin.
Copyright © 2020. Published by Elsevier Inc.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Aged
-
Aged, 80 and over
-
Betacoronavirus / immunology
-
Betacoronavirus / pathogenicity*
-
Biomarkers / blood
-
CD4-Positive T-Lymphocytes / immunology
-
CD4-Positive T-Lymphocytes / pathology
-
CD4-Positive T-Lymphocytes / virology
-
COVID-19
-
COVID-19 Testing
-
Case-Control Studies
-
China
-
Clinical Laboratory Techniques / methods
-
Coronavirus Infections / blood
-
Coronavirus Infections / diagnosis*
-
Coronavirus Infections / immunology
-
Coronavirus Infections / pathology
-
Disease Progression
-
Female
-
Gene Expression
-
Granzymes / blood
-
Granzymes / genetics*
-
Granzymes / immunology
-
Humans
-
Killer Cells, Natural / immunology*
-
Killer Cells, Natural / pathology
-
Killer Cells, Natural / virology
-
Lymphocyte Activation
-
Lymphocyte Count
-
Male
-
Middle Aged
-
Pandemics
-
Perforin / blood
-
Perforin / genetics*
-
Perforin / immunology
-
Pneumonia, Viral / blood
-
Pneumonia, Viral / diagnosis*
-
Pneumonia, Viral / immunology
-
Pneumonia, Viral / pathology
-
Prognosis
-
ROC Curve
-
SARS-CoV-2
-
Severity of Illness Index
-
T-Lymphocytes, Cytotoxic / immunology*
-
T-Lymphocytes, Cytotoxic / pathology
-
T-Lymphocytes, Cytotoxic / virology
Substances
-
Biomarkers
-
Perforin
-
Granzymes
-
GZMA protein, human